Intermountain Healthcare Joins Pieriandx’s Partner Network to Accelerate Precision Medicine
PierianDx, the leading clinical genomics informatics company, announced that Intermountain Healthcare has selected the PierianDx Clinical Genomics Workstation to advance their precision medicine program, Intermountain Precision Genomics. Intermountain Healthcare will leverage PierianDx for next-generation sequencing (NGS) variant analysis, classification, and reporting services to assist in the identification of targeted therapies and potential clinical trial opportunities for cancer patients.
“Intermountain Healthcare is widely known as a leader in precision medicine and we look forward to continued collaboration opportunities.”
PierianDx provides a SaaS platform, Clinical Genomics Workspace (CGW), the industry-leading clinical software for informatics, interpretation, and reporting of NGS data. By joining the PierianDx customer network, Intermountain Healthcare can access the genomic data within CGW’s knowledgebase, the most clinically robust database comprised of millions of biomedical findings driven by public and highly curated sources. Intermountain Healthcare joins a long list of other leading diagnostic labs and health systems using PierianDx.
“We are thrilled that Intermountain Healthcare has joined our rapidly expanding partner network,” says Michael L. Sanderson, CEO of PierianDx. “Intermountain Healthcare is widely known as a leader in precision medicine and we look forward to continued collaboration opportunities.”
Intermountain Precision Genomics is transforming healthcare by targeting treatment to deliver the highest quality care at some of the lowest costs in the nation, all while helping people live the healthiest lives possible. Intermountain Precision Genomics is a service of Intermountain Healthcare, a widely recognized leader in clinical quality improvement and efficient healthcare delivery.